1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1610
  5. Art Unit 1619
  6. Examiner Blanchard (SPE)

Examiner Blanchard David J (SPE)

1619-BLANCHARD-DAVID-J

Employment Information

Art Unit:1619 — Drug, bio-affecting and body treating compositions
Group:1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents
Classes: 424 — Drug, bio-affecting and body treating compositions
514 — Drug, bio-affecting and body treating compositions
Phone:(571) 272-0827
Email:david.blanchard@uspto.gov
Location:VA 22314
Title:Supvy Pat Examnr Biolgy
Service:23 years
Grade:GS-15

Grant Rate and Difficulty Ranking

97
3-Year Grant rate: 3% over 36 cases
Difficulty: Extremely Hard
Difficulty Percentile: 97th

With Examiner Blanchard (SPE), you have a 3% chance of getting an issued patent by 3 years after the first office action. Examiner Blanchard (SPE) is an extremely hard examiner and in the 97th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Blanchard (SPE), where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1619

Examiner Blanchard (SPE)'s grant rate is lower than that of Art Unit 1619 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Blanchard (SPE) 1.9
Art Unit 1619 2.4

Interview Benefit

Grant Rate without Interview

Examiner Blanchard (SPE) has granted 1 of 29 cases without any applicant-requested interviews for a grant rate of 3%.

Grant Rate with Interview

Examiner Blanchard (SPE) has granted 0 of 7 cases with at least one applicant-requested interview for a grant rate of 0%.

Interview Benefit

With Examiner Blanchard (SPE), conducting an interview decreases your chance of getting a patent granted by 100%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
17916230 Cd38 Inhibitors Rejection information available with a Premium Stats subscription. See our pricing. Patented View
17813681 Multispecific Single Domain Antibodies Chimeric Antigen Receptor And T-Cell Engager, Nucleic Acid, Expressing Cell Thereof, Pharmaceutical Composition For Treating Cancer, And Method For Inhibiting Proliferation Of Tumor Cell Patented View
17071033 Low Viscosity Conditioner Composition Containing Silicone Polymers Abandoned View
16947470 Biodegradable Supporting Device Abandoned View
16846529 Method For Encapsulating Hydrophobic Materials In Stabilized Yeast Cells Suitable For Processing With Polymers Abandoned View
17006129 Electrospun Anti-Adhesion Barrier Abandoned View
15645379 Compositions And Methods For Hair Improvement Abandoned View
17813447 Process For Curl-Relaxing And/or Straightening Keratin Fibres, Using Reducing Agents And Polar Organic Solvents, And Straightening Kit Abandoned View
17793245 Hair Care Composition Abandoned View
17355630 Method Of Decreasing Dermal Absorption Using Compositions Comprising Siloxane Polymer Abandoned View
17376812 Composition Comprising At Least One Anionic Surfactant, At Least Two Particular Nonionic Surfactants, At Least One Amphoteric Surfactant And At Least One Particular Cationic Polymer Abandoned View
16764800 Cationic Cellulose And Composition For Treating Hair, Skin, Or Fiber Including Same Abandoned View
17054296 Hair Cosmetic Comprising Block Copolymer Abandoned View
16762599 A Hair Care Composition Comprising Silk Fibroin Abandoned View
17610208 Hair Care Composition Comprising Piroctone Olamine Patented View
15522016 Water-In-Oil Emulsion Sunscreen Cosmetic Patented View
15942085 Kits And Methods For Treating Hair Abandoned View
15733805 Multicomponent Composition (Michael Addition) Patented View
17510478 Warming Conditioner Patented View
14994169 Vegetarian Capsules Containing Supercritical Herbal Extracts Abandoned View
15354794 Application Of Compound Mixtures To Control Oxidation Abandoned View
15430729 Compositions And Methods For Enhancing Exercise Performance Abandoned View
14986904 Cross-Linkable Tissue Bulking Compositions Abandoned View
14905990 Formulations Containing Amorphous Dapagliflozin Abandoned View
16012789 Angstrom Silver Injection For Cancer Inhibition, Preparation Method And Application Thereof Abandoned View
15556504 Use Of Isolated Fractions Of Mastic Gum For Treating Optic Neuropathy Patented View
15756864 Honey Eluting Cryogel For Tissue Engineering Abandoned View
15099193 Implantable Graphene Membranes With Low Cytotoxicity Abandoned View
15514799 Sutureless Repair Of Soft Tissue Abandoned View
15294114 Inhalable Medicament Abandoned View
15819070 Tableted Compositions Containing Atazanavir Abandoned View
14908494 Vesicles Abandoned View
15753556 Bioactive Polymer For Bone Regeneration Abandoned View
15023786 Fixation Of Vaccine Formulations On Devices For Epidermal Immunisation By Oily Adjuvants Abandoned View
15126469 Antimicrobial Air Sanitizer Compositions And Their Use Abandoned View
15102355 Kind Of Absorbable High Strength And Toughness Corrosion-Resistant Zinc Alloy Implant Material For Human Body Abandoned View
15492363 Compositions And Methods For Stabilization Of Active Agents Abandoned View
15045912 Natural Antimicrobial Compositions Abandoned View
15326289 Polycomplex Gel For Treating Diseases Of Intestinal/digestive Tract Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.